Peripheral malignancies, notably bronchogenic carcinomas, are common targets for ENB. As these malignancies are often among tobacco smokers, patients often suffer from comorbidities, such as chronic obstructive pulmonary disease and coronary artery disease, which make them poor candidates for invasive diagnostic procedures.